Clinical Trials¶
642 poster abstracts, ~294,000 words. Session transcripts are deferred — CT minisymposiums are largely serial readings of the posters; the 294K-word poster corpus substantively covers the track.
What's here¶
- Phase I/II/III core sessions — 191 posters across 8 in-progress / first-in-human minisymposium poster sessions
- Late-Breaking Research: Clinical Research — 66 posters across LBR Clinical 1-4
- Biostatistics in Clinical Trials / Surgical Oncology — 13 posters on design methodology
- Biomarker-correlative CT posters — 50+ Biomarkers Predictive of Therapeutic Benefit posters
- CT-adjacent spillover — 385 posters across 100+ subject-specific sessions (lung, breast, ADCs, CAR-T, etc.) whose abstracts mention Phase I/II/III or "clinical trial"
Overlap with other topics: 76 also in Single-Cell & Spatial Omics, 24 in Bioinfo / Comp Bio / AI Methods, 6 in Virtual Cells. 546 are unique to this topic.
Session transcripts deferred¶
25 CT parent sessions were identified but not extracted. Rationale:
- CT minisymposium talks at AACR are typically authors reading their own poster abstracts verbatim. The 294K-word poster corpus already covers the content.
- Extraction requires Swapcard CAPTCHA handling + per-session navigation + Vimeo config capture; Chrome downloads were blocked during the extraction session.
If specific sessions are needed, the IDs are documented in transcripts/clinical-trials/README.md of the aacr-2026 GitHub repo. Tier-1 candidates:
- Clinical Trial Design Workshop: Real World Evidence
- Bayesian and Model-Assisted Designs for Early-Phase Trials
- Bridging the Gap: Multilevel Strategies to Expand Access to Cancer Clinical Trials
- New Drugs on the Horizon: Part 1 / 2 / 3
- Advancing Patient-Centered Clinical Trials
- Modernizing Clinical Trial Communication (NCI AI toolkit)